Hormone therapy for preventing cardiovascular disease in post-menopausal women (Q24187326)

cardiovascular disease in women

inferred from title

0 references

author

Louise Hartley

2

0 references

Xavier Bonfill Cosp

6

0 references

Marta Roqué

5

0 references

author name string

Henry MP Boardman

1

0 references

Anne Eisinga

3

0 references

Caroline Main

4

0 references

Rafael Gabriel Sanchez

7

0 references

Beatrice Knight

Cochrane Database of Systematic Reviews

8

0 references

publication date

10 March 2015

0 references

published in

0 references

cites work

Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The effect of hormone replacement on physical performance in community-dwelling elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Long-term effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The heart and estrogen/progestin replacement study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Women's angiographic vitamin and estrogen trial: design and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen after ischemic stroke: clinical basis and design of the Women's Estrogen for Stroke Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Implementation of the women's health initiative study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The Women's Health Initiative recruitment methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Calcitonin and postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

A randomized, placebo-controlled trial of the effects of physical exercises and estrogen therapy on health-related quality of life in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Pulse pressure and coronary atherosclerosis progression in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Striking increases in carotid artery wall thickness in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Recruitment of postmenopausal women in the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Women's health initiative studies of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Unopposed estradiol therapy in postmenopausal women: results from two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

1 and 2 mg 17beta-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Brain volumes, cognitive impairment, and conjugated equine estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Menopause and risk of cardiovascular disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone therapy for preventing cardiovascular disease in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen replacement therapy, atherosclerosis, and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Hormone replacement therapy and stroke: risk, protection or no effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Sex differences in use of coronary revascularization in elderly patients after acute myocardial infarction: a tale of two therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

A case-control study of myocardial infarction in relation to use of estrogen supplements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Prolonged estrogen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Age at Natural Menopause and Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Increased incidence of coronary heart disease in women castrated prior to the menopause

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Ten years post-menopausal hormone replacement therapy--effect on lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Estrogen replacement therapy: an overview.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Does age at natural menopause affect mortality from ischemic heart disease?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

The ERA trial: findings and implications for the future.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Development of a brief screening instrument for detecting depressive disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

A practical guide to prescribing hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002229.PUB4

7 January 2021